Research Paper Volume 16, Issue 3 pp 2340—2361

5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia

class="figure-viewer-img"

Figure 3. Clinical characteristics of m5C regulators in acute myeloid leukemia (AML). Expression of m5C regulators between (A) age groups, (B) CR groups, (C) FAB groups, (D) male and female, (E) survival status, and (F) before and after treatment in AML patients. *p < 0.05, **p < 0.01, ***p < 0.001.